Skip to main content
logo
Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.8299
-0.0002 (-0.02%)
Sep 16, 2026, 8:54 AM EDT - Market open

Genenta Science Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23
Net Income
-6.53-7.62-8.7-8.81-8.91-8.92-8.92-10.29-11.65-12.39
Depreciation & Amortization
0.030.030.040.040.040.040.040.040.040.03
Loss (Gain) From Sale of Investments
0.10.070.040.02-00.010--0
Stock-Based Compensation
1.011.021.040.940.850.70.560.650.740.82
Other Operating Activities
0.10.10.10.080.060.060.060.070.080.1
Change in Accounts Payable
1.310.860.410.220.030.070.12-0.31-0.73-0.39
Change in Other Net Operating Assets
-2.89-2.76-2.62-0.471.692.072.461.380.310.01
Operating Cash Flow
-6.87-8.28-9.7-7.97-6.24-5.96-5.68-8.44-11.21-11.82
Operating Cash Flow Growth (YoY)
----------

Investing Activities

Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23
Capital Expenditures
-0.01-0.01-0.01-0.01-0-0-0-0.01-0.01-0.03
Investment in Securities
-14.54-8.19-1.842.526.893.15-0.59-7.73-14.88-12.43
Investing Cash Flow
-14.54-8.2-1.852.516.883.15-0.59-7.74-14.89-12.46

Financing Activities

Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23
Long-Term Debt Issued
7.5---------
Total Debt Issued
7.57.57.53.75------
Net Debt Issued (Repaid)
7.57.57.53.75------
Other Financing Activities
14.798.882.981.620.270.270.270.1400
Financing Cash Flow
22.2916.3810.485.370.270.270.270.1400

Net Cash Flow

Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23
Foreign Exchange Rate Adjustments
0.070.070.060.02-0.02-0.02-0.02-0.01-0.01-0
Net Cash Flow
0.95-0.03-1.01-0.060.89-2.57-6.03-16.06-26.1-24.28

Free Cash Flow

Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23
Free Cash Flow
-6.88-8.29-9.71-7.98-6.24-5.97-5.69-8.45-11.22-11.84
Free Cash Flow Growth (YoY)
----------
Free Cash Flow Per Share
-0.35-0.43-0.52-0.43-0.34-0.33-0.31-0.46-0.62-0.65
Levered Free Cash Flow
-3.1-3.71-6.38-6.83-4.18-4.23-4.45-5.07-7.57-8.12
Unlevered Free Cash Flow
-3.1-3.71-6.38-6.83-4.18-4.23-4.45-5.07-7.57-8.12

Additional Metrics

Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23
Change in Working Capital
-1.58-1.9-2.21-0.251.722.152.571.08-0.42-0.38
SEC Filings: 10-K · 10-Q